Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3β,17β-diol to risk of breast cancer in postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 3, 1997, Pages 177-181

  Dorgan, Joanne F ^a   Stanczyk, Frank Z ^b   Longcope, Christopher ^b   Stephenson Jr , Hugh E ^d   Chang, Lilly ^c   Miller, Rosetta ^d   Franz, Charlene ^c   Falk, Roni T ^a   Kahle, Lisa ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ANABOLIC AGENTS; ANDROSTENEDIOL; BIAS (EPIDEMIOLOGY); BLOOD DONORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MIDDLE AGED; MISSOURI; ODDS RATIO; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030932246     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gordon, G. B., Bush, T. L., Helzlsouer, K. J., Miller, S. R., and Comstock, G. W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res., 50: 3859-3862, 1990.
2. Helzlsouer, K. J., Gordon, G. B., Alberg, A. J., Bush, T. L., and Comstock, G. W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res., 52: 1-4, 1992.
3. Zumoff, B., Levin, J., Rosenfeld, R. S., Markham, M., Strain, G. W., and Fukushima, D. K. Abnormal 24 h mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res., 41: 3360-3363, 1981.
4. Boccuzzi, G., Aragno, M., Brignardello, E., Tamagno, E., Conti, G., Di Monoco, M., Racca, S., Danni, O., and Di Carlo, F. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Anticancer Res., 12: 1479-1484, 1992.
5. 7 human breast cancer cells. Cancer Res., 41: 4720-4726, 1981.
6. Najid, A., and Habrioux, G. Biological effects of adrenal androgens on MCF-7 and BT-20 human breast cancer cells. Oncology, 47: 269-274, 1990.
7. Boccuzzi, G., Brignardello, E., Di Monoco, M., Forte, C., Leonardi, L., and Pizzini, A. Influence of dehydroepiandrosterone and 5-en-androstene-3β,17β-diol on the growth of MCF-7 human breast cancer cells induced by 17β-estradiol. Anticancer Res., 12: 799-804, 1992.
8. Boccuzzi, G., Brignardello, E., Di Monoco, M., Gatto, V., Leonardi, L., Pizzini, A., and Gallo, M. 5-En-androstene-3β,17β-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are block by oestradiol. Br. J. Cancer, 70: 1035-1039, 1994.
9. Dorgan, J. F., Longcope, C., Stephenson, H. E., Falk, R. T., Miller, R., Franz, C., Kahle, L., Campbell, W. S., Tangrea, J. A., and Schatzkin, A. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol., Biomarkers & Prev., 5: 533-539, 1996.